StartsideMEHCQ • OTCMKTS
add
Chrome Holding Co
3,20 $
Etterbørs:(1,25 %)−0,040
3,16 $
Stengt: 17. okt., 16:02:12 GMT-4 · USD · OTCMKTS · Ansvarsfraskrivelse
Forrige sluttkurs
3,16 $
Dagsintervall
3,13 $ - 3,20 $
Årsintervall
0,47 $ - 6,21 $
Markedsverdi
88,13 mill. USD
Gjennomsnittlig volum
50,03k
P/E-tall
-
Utbytte
-
Hovedbørs
OTCMKTS
Markedsnyheter
Økonomi
Resultatregnskap
Omsetning
Nettoomsetning
(USD) | juni 2025info | Endring år til år |
---|---|---|
Omsetning | 25,42 mill. | −37,10 % |
Driftskostnader | 44,24 mill. | −43,21 % |
Nettoomsetning | −23,83 mill. | 65,67 % |
Netto resultatmargin | −93,74 | 45,41 % |
Fortjeneste per aksje | — | — |
EBITDA | −28,49 mill. | 46,78 % |
Faktisk avgiftssats | — | — |
Balanseregnskap
Totale aktiva
Totale passiva
(USD) | juni 2025info | Endring år til år |
---|---|---|
Kontant / kortsiktige inv. | 39,83 mill. | −76,57 % |
Totale aktiva | 144,33 mill. | −60,79 % |
Totale passiva | 187,19 mill. | −16,64 % |
Total egenkapital | −42,86 mill. | — |
Utestående aksjer | 27,54 mill. | — |
P/B-forhold | −2,03 | — |
Avkastning på aktiva | −50,47 % | — |
Avkastning på kapital | 438,85 % | — |
Kontantstrøm
Netto kontantstrøm
(USD) | juni 2025info | Endring år til år |
---|---|---|
Nettoomsetning | −23,83 mill. | 65,67 % |
Kontantstrøm fra drift | −28,99 mill. | 33,00 % |
Kontanter fra investering | −1,03 mill. | 10,64 % |
Kontanter fra finansiering | 24,28 mill. | 269 711,11 % |
Netto kontantstrøm | −5,74 mill. | 87,07 % |
Fri kontantstrøm | 22,86 mill. | 281,90 % |
Om
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.
Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.
The company had a previously confrontational relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Grunnlagt
apr. 2006
Hovedkvarter
Nettsted
Ansatte
261